Motomasa Takahashi

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Fujifilm Corporation. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motomasa Takahashi. Retrieved from https://idiyas.com/inventor/motomasa-takahashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

11 out of 16,996

Fujifilm Corporation

patents

Years Active: 2015-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509484 - Method of producing nucleic acid compound, and nucleic acid compound (2025-12-30),

2. 12479881 - Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic aromatic hydrocarbon compound (2025-11-25),

3. 12370143 - Compound or salt thereof and lipid particles (2025-07-29),

4. 12325727 - Method for producing peptide compound, protective group-forming reagent, and aromatic heterocyclic compound (2025-06-10),

5. 12285525 - Compound or salt thereof and lipid particles (2025-04-29),

6. 10689358 - Method for producing indazole compound, and indazole compound (2020-06-23),

7. 10570112 - Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same (2020-02-25),

8. 10323005 - Aromatic compound production method (2019-06-18),

9. 10093645 - Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same (2018-10-09),

10. 9475835 - Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same (2016-10-25),

11. 9221865 - Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same (2015-12-29),

Title: Motomasa Takahashi: Innovator in Nucleic Acid and Peptide Compounds

Introduction

Motomasa Takahashi is a prominent inventor based in Ashigarakami, Japan. He has made significant contributions to the fields of nucleic acid and peptide compound production. With a total of 11 patents, his work has advanced the understanding and application of these compounds in various scientific domains.

Latest Patents

Takahashi's latest patents include a method of producing nucleic acid compounds and a method for producing peptide compounds. The first patent details a method where a nucleic acid compound has a protective structure at either the 3-position or 5-position of a ribose structure. This innovative approach utilizes a condensed polycyclic aromatic hydrocarbon ring, enhancing the stability and functionality of the nucleic acid compound. The second patent focuses on producing peptide compounds using similar protective group-forming reagents, which also involve condensed polycyclic aromatic hydrocarbon compounds.

Career Highlights

Motomasa Takahashi is currently associated with Fujifilm Corporation, where he continues to push the boundaries of research and development in his field. His work has not only contributed to the scientific community but has also positioned Fujifilm as a leader in innovative solutions related to nucleic acids and peptides.

Collaborations

Throughout his career, Takahashi has collaborated with notable colleagues, including Makoto Takahashi and Yuuta Fujino. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Motomasa Takahashi's contributions to the fields of nucleic acid and peptide compounds are noteworthy. His innovative methods and collaborative spirit continue to inspire advancements in scientific research.

Profile summary based on public USPTO records.